Gilead Gets Buy, Amgen Holds: Biopharma Calls Roil Markets
Wall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
This list highlights altcoins with clear real-world use cases and tangible value, helping readers prioritize projects with practical impact.
24,805 articlesWall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Bitcoin steadies near the $70,000 mark as oil prices leap and geopolitical tensions rise. Analysts weigh whether the ...
ECL, EMN, and BCC report mixed quarters as 2026 guidance and cost actions set the tone for a volatile chemicals secto...
Energy costs are climbing in early 2026 and are expected to ripple through U.S. supply chains, pressuring prices on g...
Disney faces a growing disney narrative problem wall as Wall Street questions leadership, strategy, and long-term pro...
A wave of AI-powered servicing messages is misinforming borrowers, exposing a governance gap in mortgage operations. ...
Roadrunner, the AI-powered CPQ startup, today disclosed a $27 million funding round led by Kleiner Perkins and FOUNDE...
Ford shares jumped roughly 7% as Q1 momentum and Ford Pro strength lifted the full-year EBIT outlook, putting Ford ah...
NVIDIA and Alphabet reveal divergent AI strategies, highlighting hardware rails versus cloud-powered services, and si...
AI-driven leaders propel gains, yet concentration and margin debt raise the odds of a sharper pullback. Investors wei...
Economists say AI is weighing on hiring in the U.S. as the labor market cools, signaling a shift for workers and comp...
Federal Reserve Chair Powell warns that another December rate cut is not guaranteed as policymakers remain divided on...